Consistent Export Growth: 9.62% CAGR Over 8 Years
India's exports under HSN Sub-Chapter 2937 have grown at a compound annual rate of 9.62% over 8 fiscal years, rising from ₹1,533.73 Crore in FY 2018-19 to ₹2,917.75 Crore in FY 2025-26.
HSN Sub Chapter 2937 represents Hormones & derivatives, synthesized under GST classification. This code helps businesses identify Hormones & derivatives, synthesized correctly for billing, taxation, and trade purposes. With HSN Sub Chapter 2937, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Hormones & derivatives, synthesized.
Manage correct HSN codes and GST rates with BUSY.
GST Rate for Hormones & derivatives, synthesized under HSN Code 2937. Understand current tax rates, exemptions, and legal classifications to ensure accurate billing and GST filing.
Chapter No
29HSN Code
HSN Description
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones
New GST Rate
5% for drugs and bulk drugs (APIs) of this heading, including their salts and esters; 18% for other goods.
Old GST Rate
Following tariff HSN codes fall under Hormones & derivatives, synthesized.
Tariff HSN
Description
Polypeptide hormones, protein hormones and glycoprotein hormones, their dervatives and structural analogues :Somatotropin, its derivatives and structural analogues
Tariff HSN
Description
Polypeptide hormones, protein hormones and glycoprotein hormones, their dervatives and structural analogues :Insulin and its salts
Tariff HSN
Description
Polypeptide hormones, protein hormones and glycoprotein hormones, their dervatives and structural analogues :Other
Tariff HSN
Description
Steroidal hormones, their derivatives and structural analogues :Cortisone, hydrocortisone, prednisone, (dehydrocortisone) and prednisolone (dehydrohydrocortisone)
Tariff HSN
Description
Steroidal hormones, their derivatives and structural analogues :Halogenated derivatives of corticosteroidal harmones
Tariff HSN
Description
Steroidal hormones, their derivatives and structural analogues :Oestrogens and progestogens
Tariff HSN
Description
Steroidal hormones, their derivatives and structural analogues :Other
Tariff HSN
Description
Epinephrine
Tariff HSN
Description
Prostaglandins,thromboxanes, leukotrienes, their derivatives and structural analogues
Tariff HSN
Description
Other:Catecholamine hormones,their derivatives and structural analogues:Epinethrine
Tariff HSN
Description
Other:Catecholamine hormones,their derivatives and structural analogues:Other
Tariff HSN
Description
Other: Amino-acid derivatives
Tariff HSN
Description
Other:Other
BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.
India’s Exports
FY 2025-26₹2,918 Cr
0.0748% of India’s total exports
India’s Imports
FY 2025-26₹3,699 Cr
0.0539% of India’s total imports
Trade Balance
FY 2025-26−₹781 Cr
Surplus rank #920 of 1233 subchapters
% of Chapter 29
FY 2025-261.62%
Share of Chapter 29’s total exports in FY 2025-26
Import side: 1.65% of Chapter 29’s imports
Rank Within Chapter 29
FY 2025-26#20 of 42
Position by export value among subchapters in Chapter 29
Import-side rank: #19 of 42
At a glance
9.62%
Export CAGR
FY 2018-19 → FY 2025-26 · 8 fiscal years
#218
National Export Rank
of 1233 subchapters by export value, FY 2025-26
+18.97%
Peak Growth Year
FY 2023-24 · strongest single-year move
1.62%
Contribution to Ch. 29
Share of Chapter 29 exports in FY 2025-26
8-year export and import data, FY 2018-19 to FY 2025-26, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.
Balance
−698.31
Exports
1,533.73 ₹ Cr
0.0668% share
— YoY
1.20% of Ch. 29
Imports
2,232.04 ₹ Cr
0.0622% share
— YoY
1.43% of Ch. 29
Balance
−504.26
Exports
1,711.17 ₹ Cr
0.0775% share
+11.57% YoY
1.38% of Ch. 29
Imports
2,215.43 ₹ Cr
0.0660% share
−0.74% YoY
1.58% of Ch. 29
Balance
−263.91
Exports
1,921.91 ₹ Cr
0.0894% share
+12.32% YoY
1.44% of Ch. 29
Imports
2,185.82 ₹ Cr
0.0750% share
−1.34% YoY
1.50% of Ch. 29
Balance
−578.20
Exports
1,934.71 ₹ Cr
0.0616% share
+0.67% YoY
1.18% of Ch. 29
Imports
2,512.91 ₹ Cr
0.0550% share
+14.96% YoY
1.18% of Ch. 29
Balance
−830.91
Exports
2,145.34 ₹ Cr
0.0593% share
+10.89% YoY
1.25% of Ch. 29
Imports
2,976.25 ₹ Cr
0.0518% share
+18.44% YoY
1.28% of Ch. 29
Balance
−618.18
Exports
2,552.28 ₹ Cr
0.0705% share
+18.97% YoY
1.52% of Ch. 29
Imports
3,170.46 ₹ Cr
0.0565% share
+6.53% YoY
1.43% of Ch. 29
Balance
−677.33
Exports
2,735.54 ₹ Cr
0.0739% share
+7.18% YoY
1.61% of Ch. 29
Imports
3,412.87 ₹ Cr
0.0560% share
+7.65% YoY
1.52% of Ch. 29
Balance
−781.09
Exports
2,917.75 ₹ Cr
0.0748% share
+6.66% YoY
1.62% of Ch. 29
Imports
3,698.84 ₹ Cr
0.0539% share
+8.38% YoY
1.65% of Ch. 29
CAGR · 8-Year
Exports
9.62% /yr
Imports
7.48% /yr
reference, FY 2025-26
Export
₹1,80,641.82 Cr
Import
₹2,24,278.97 Cr
Trade Balance
−43,637.15
India's exports under HSN Sub-Chapter 2937 have grown at a compound annual rate of 9.62% over 8 fiscal years, rising from ₹1,533.73 Crore in FY 2018-19 to ₹2,917.75 Crore in FY 2025-26.
In FY 2025-26, HSN Sub-Chapter 2937 ranks #218 out of 1233 subchapters by total export value. Within Chapter 29, it ranks #20 of 42. By trade surplus, it ranks #920 of 1233.
The strongest single-year export movement for HSN Sub-Chapter 2937 was recorded in FY 2023-24, when exports surged by 18.97% over the prior year.
In FY 2025-26, India's imports of ₹3,698.84 Cr exceeded exports of ₹2,917.75 Cr, resulting in a trade deficit of ₹781.09 Crore — ranking #920 of 1233 by surplus magnitude.
India's imports under HSN Sub-Chapter 2937 have grown at 7.48% CAGR, reaching ₹3,698.84 Crore in FY 2025-26.
Among the 42 subchapters under Chapter 29, HSN Sub-Chapter 2937 ranks #20 by export value — accounting for 1.62% of the chapter's total exports in FY 2025-26. On the import side, it holds 1.65% share (rank #19).
Clear answers to common queries about HSN Sub Chapter 2937 and GST compliance.
It includes Hormones & derivatives, synthesized
Some entries use MRP/weight‑based conditions for classification. Keep pack size, retail marking and brand status on records and invoice to support the chosen HSN.
Generate an e‑way bill when the consignment value exceeds ₹50,000, unless exempted for the transaction. E‑invoicing depends on turnover (AATO threshold as notified) for B2B supplies, not on the item itself.
Reverse charge in goods is notified only for specific categories. Most regular B2B sales of Hormones & derivatives, synthesized are forward charge. Check the current notifications for any special cases before deciding.
Ensure registration requirements are met and reconcile the operator’s TCS statements with your GSTR‑2B/3B. Map SKU descriptions to HSN to reduce mismatches and returns.
Using a broad or incorrect HSN, ignoring material/form (e.g., raw vs processed), or mixing goods and services on one line. Always match wording to the HSN Notes and keep a classification working paper.